Cysteine and obesity

Obesity

Volumn 20, Issue 3, 2012, Pages 473-481

  Elshorbagy, Amany K ^a,b   Smith, A David ^a   Kozich, Viktor ^c   Refsum, Helga ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CILASTATIN; CYSTATHIONASE INHIBITOR; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; ENZYME INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; HYDROGEN PEROXIDE; INSULIN; METHIONINE; PROPARGYLGLYCINE; SALAZOSULFAPYRIDINE; SULFUR AMINO ACID; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; BODY COMPOSITION; BODY MASS; DIET RESTRICTION; DIET SUPPLEMENTATION; DOWN SYNDROME; DRUG MECHANISM; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; HOMOCYSTINURIA; HUMAN; INBORN ERROR OF METABOLISM; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; REVIEW; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

BODY MASS INDEX; BODY WEIGHT; CYSTEINE; FEMALE; HUMANS; MALE; METHIONINE; OBESITY; RISK FACTORS;

ANIMALIA;

EID: 84857687536     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.93     Document Type: Review

References (97)

1. Brosnan JT, Brosnan ME. The sulfurcontaining amino acids: an overview. J Nutr 2006;136:1636S-1640S.
2. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr 2004;24:481-509.
3. Lu SC. Regulation of glutathione synthesis. Curr Top Cell Regul 2000;36:95-116.
4. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE; European Concerted Action Project. Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 2001;103:2544-2549.
5. Jhee KH, Kruger WD. The role of cystathionine β-synthase in homocysteine metabolism. Antioxid Redox Signal 2005;7:813-822.
6. Vitvitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R. Redox regulation of homocysteinedependent glutathione synthesis. Redox Rep 2003;8:57-63.
7. Whitfield JB. γ glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
8. Barrios R, Shi ZZ, Kala SV et al. Oxygeninduced pulmonary injury in γ-glutamyl transpeptidase-deficient mice. Lung 2001;179:319-330.
9. Lieberman MW, Wiseman AL, Shi ZZ et al. Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996;93:7923-7926.
10. Hammond JW, Potter M, Sim KG, Wilcken B. Reduced glutathione, γ-glutamylcysteine, cysteine and.-glutamylglutamine in γ-glutamyltransferase deficiency. J Inherit Metab Dis 1999;22:235-239.
11. Stipanuk MH, Dominy JE Jr, Lee JI, Coloso RM. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr 2006;136:1652S-1659S.
12. Simpson RC, Hill FW, Freedland RA. Gluconeogenesis from l-cysteine in the perfused rat liver. J Nutr 1975;105:379-384.
13. Stipanuk MH, Ueki I. Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis 2011;34:17-32.
14. Stipanuk MH, Londono M, Lee JI, Hu M, Yu AF. Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J Nutr 2002;132:3369-3378.
15. El-Khairy L, Ueland PM, Nygård O, Refsum H, Vollset SE. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999;70:1016-1024.
16. El-Khairy L, Vollset SE, Refsum H, Ueland PM. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem 2003;49:113-120.
17. van den Brandhof WE, Haks K, Schouten EG, Verhoef P. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 2001;157:403-409.
18. Baines M, Kredan MB, Davison A et al. The association between cysteine, bone turnover, and low bone mass. Calcif Tissue Int 2007;81:450-454.
19. Giral P, Jacob N, Dourmap C et al. Elevated.-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:587-593.
20. Lin J, Lee IM, Song Y et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res 2010;70:2397-2405.
21. Elshorbagy AK, Nurk E, Gjesdal CG et al. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am J Clin Nutr 2008;88:738-746.
22. Aasheim ET, Elshorbagy A, Diep LM et al. Effect of bariatric surgery on sulfur amino acids and glutamate. Br J Nutr 2011 (doi:10.1017/S0007114511000201) .
23. Iwasaki T, Yoneda M, Kawasaki S et al. Hepatic fat content-independent association of the serum level of.-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Diabetes Res Clin Pract 2008;79:e13-e14.
24. Elshorbagy AK, Refsum H, Smith AD, Graham IM. The association of plasma cysteine and.-glutamyltransferase with BMI and obesity. Obesity (Silver Spring) 2009;17:1435-1440.
25. Pieniazek D, Grabarek Z, Rakowska M. Quantitative determination of the content of available methionine and cysteine in food proteins. Nutr Metab 1975;18:16-22.
26. Demirkol O, Adams C, Ercal N. Biologically important thiols in various vegetables and fruits. J Agric Food Chem 2004;52:8151-8154.
27. Fettman MJ, Valerius KD, Ogilvie GK et al. Effects of dietary cysteine on blood sulfur amino acid, glutathione, and malondialdehyde concentrations in cats. Am J Vet Res 1999;60:328-333.
28. Cho ES, Johnson N, Snider BC. Tissue glutathione as a cyst (e) ine reservoir during cystine depletion in growing rats. J Nutr 1984;114:1853-1862.
29. Helms RA, Storm MC, Christensen ML, Hak EB, Chesney RW. Cysteine supplementation results in normalization of plasma taurine concentrations in children receiving home parenteral nutrition. J Pediatr 1999;134:358-361.
30. Virtanen JK, Voutilainen S, Rissanen TH et al. High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis 2006;16:113-120.
31. Elshorbagy AK, Valdivia-Garcia M, Graham IM et al. The association of fasting plasma sulfurcontaining compounds with BMI, plasma lipids and apolipoproteins. Nutr Metab Cardiovasc Dis 2011 (doi:10.1016/j.numecd.2011.01. 008).
32. Newgard CB, An J, Bain JR et al. A branchedchain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326.
33. Proenza AM, Roca P, Crespí C, Lladó I, Palou A. Blood amino acid compartmentation in men and women with different degrees of obesity. J Nutr Biochem 1998;9:697-704.
34. Janosíková B, Pavlíková M, Kocmanová D et al. Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. Mol Genet Metab 2003;79:167-175.
35. Felig P, Wahren J, Hendler R, Brundin T. Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest 1974;53:582-590.
36. Holm G, Sullivan L, Jagenburg R, Björntorp P. Effects of physical training and lean body mass of plasma amino acids in man. J Appl Physiol 1978;45:177-181.
37. She P, Van Horn C, Reid T et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branchedchain amino acid metabolism. Am J Physiol Endocrinol Metab 2007;293:E1552-E1563.
38. Roizen NJ, Patterson D. Down's syndrome. Lancet 2003;361:1281-1289.
39. Allison DB, Gomez JE, Heshka S et al. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord 1995;19:858-861.
40. Pogribna M, Melnyk S, Pogribny I et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 2001;69:88-95.
41. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Molecular and Metabolic Bases of Inherited Disease. McGraw-Hill: New York, 1995, pp 1279-1327.
42. Kraus JP, Kožich V. Cystathionine β synthase and its deficiency. In: Carmel R, Jacobsen DW (eds.) Homocysteine in Health and Disease. Cambridge University Press: Cambridge, 2001, pp 223-244.
43. Brenton DP, Dow CJ, James JI, Hay RL, Wynne-Davies R. Homocystinuria and Marfan's syndrome. A comparison. J Bone Joint Surg Br 1972;54:277-298.
44. Gibson JB, Carson NA, Neill DW. Pathological findings in homocystinuria. J Clin Pathol 1964;17:427-437.
45. Kaur M, Kabra M, Das GP, Suri M, Verma IC. Clinical and biochemical studies in homocystinuria. Indian Pediatr 1995;32:1067-1075.
46. Mann GV, Mcnally A. Experimental atherosclerosis, Effects of sulfur compounds on hypercholesteremia and growth in cysteindeficient monkeys. Am J Clin Nutr 1960;8:491-498.
47. Okawa H, Morita T, Sugiyama K. Cysteine supplementation decreases plasma homocysteine concentration in rats fed on a low-casein diet in rats. Biosci Biotechnol Biochem 2007;71:91-97.
48. Pollack PF, Rivera A Jr, Rassin DK, Nishioka K. Cysteine supplementation increases glutathione, but not polyamine, concentrations of the small intestine and colon of parenterally fed newborn rabbits. J Pediatr Gastroenterol Nutr 1996;22:364-372.
49. Kawakami Y, Ohuchi S, Morita T, Sugiyama K. Hypohomocysteinemic effect of cysteine is associated with increased plasma cysteine concentration in rats fed diets low in protein and methionine levels. J Nutr Sci Vitaminol 2009;55:66-74.
50. Tozer RG, Tai P, Falconer W et al. Cysteinerich protein reverses weight loss in lung cancer patients receiving chemotherapy or radiotherapy. Antioxid Redox Signal 2008;10:395-402.
51. Ball RO, Courtney-Martin G, Pencharz PB. The in vivo sparing of methionine by cysteine in sulfur amino acid requirements in animal models and adult humans. J Nutr 2006;136:1682S-1693S.
52. Pieniazek D, Rakowska M, Szkilladziowa W, Grabarek Z. Estimation of available methionine and cysteine in proteins of food products by in vivo and in vitro methods. Br J Nutr 1975;34:175-190.
53. Malloy VL, Krajcik RA, Bailey SJ et al. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 2006;5:305-314.
54. Rizki G, Arnaboldi L, Gabrielli B et al. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 2006;47:2280-2290.
55. Flowers MT, Ntambi JM. Role of stearoylcoenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol 2008;19:248-256.
56. Nimni ME, Han B, Cordoba F. Are we getting enough sulfur in our diet? Nutr Metab (Lond) 2007;4:24.
57. Rosell M, Appleby P, Spencer E, Key T. Weight gain over 5 years in 21, 966 meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int J Obes (Lond) 2006;30:1389-1396.
58. Newby PK, Tucker KL, Wolk A. Risk of overweight and obesity among semivegetarian, lactovegetarian, and vegan women. Am J Clin Nutr 2005;81:1267-1274.
59. Atamasirikul K, Kajanachumpol S, Wilairat P, Tantibhedhyangkul P. Clinical usefulness of a HPLC method for simultaneous quantitation of plasma homocysteine and cysteine. J Med Assoc Thai 2008;91:338-344.
60. Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci 2007;4:72-82.
61. Epner DE, Morrow S, Wilcox M, Houghton JL. Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction. Nutr Cancer 2002;42:158-166.
62. Elshorbagy AK, Valdivia-Garcia M, Refsum H et al. Sulfur amino acids in methioninerestricted rats: hyperhomocysteinemia. Nutrition 2010;26:1201-1204.
63. Elshorbagy AK, Valdivia-Garcia M, Mattocks DA et al. Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J Lipid Res 2011;52:104-112.
64. Elshorbagy AK, Church C, Valdivia-Garcia M, Smith AD, Refsum H, Cox R. Dietary cystine level affects metabolic rate and glycaemic control in adult mice. J Nutr Biochem 2011: in press.
65. Chadha S, Kanwar U, Sanyal SN. Effect of sulfasalazine on adaptive and functional changes in intestine of normal and proteincaloriemalnourished rats. Res Exp Med (Berl) 1992;192:105-113.
66. Badiou S, Bellet H, Lehmann S, Cristol JP, Jaber S. Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment. Clin Chem Lab Med 2005;43:332-334.
67. Usui T. Toxicological study of imipenem/cilastatin sodium (II). Subacute and chronic toxicity studies in rats. Chemotherapy 1985;33(Suppl. 4):129-180.
68. MacDonald JS. Toxicological study of imipenem/cilastatin sodium (III). Subacute and chronic toxicity studies in the rhesus monkey. Chemotherapy 1985;33(Suppl. 4):181-206.
69. Uren JR, Ragin R, Chaykovsky M. Modulation of cysteine metabolism in mice-effects of propargylglycine and l-cyst (e) ine-degrading enzymes. Biochem Pharmacol 1978;27:2807-2814.
70. Lands LC, Grey VL, Smountas AA. Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol 1999;87:1381-1385.
71. Demling RH, De Santi L. Effect of a hypocaloric diet, increased protein intake and resistance training on lean mass gains and fat mass loss in overweight police officers. Ann Nutr Metab 2000;44:21-29.
72. Bouthegourd JC, Roseau SM, Makarios-Lahham L et al. A preexercise a-lactalbumin-enriched whey protein meal preserves lipid oxidation and decreases adiposity in rats. Am J Physiol Endocrinol Metab 2002;283:E565-E572.
73. Hayes A, Cribb PJ. Effect of whey protein isolate on strength, body composition and muscle hypertrophy during resistance training. Curr Opin Clin Nutr Metab Care 2008;11:40-44.
74. Hildebrandt W, Hamann A, Krakowski-Roosen H et al. Effect of thiol antioxidant on body fat and insulin reactivity. J Mol Med 2004;82:336-344.
75. Kim JR, Ryu HH, Chung HJ et al. Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation. Exp Mol Med 2006;38:162-172.
76. Hultberg B, Andersson A, Masson P, Larson M, Tunek A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest 1994;54:417-422.
77. Ventura P, Panini R, Abbati G, Marchetti G, Salvioli G. Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy. Pharmacology 2003;68:105-114.
78. Wiklund O, Fager G, Andersson A et al. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein (a) levels. Atherosclerosis 1996;119:99-106.
79. Guyton AC, Hall JE. Textbook of Medical Physiology. 11th edn. Elsevier Saunders: Philadelphia, PA, 2006.
80. Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 2001;276:21938-21942.
81. Mahadev K, Wu X, Zilbering A et al. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 2001;276:48662-48669.
82. 2 formation. J Biol Chem 1977;252:560-562.
83. Mukherjee SP, Mukherjee C. Stimulation of pyruvate dehydrogenase activity in adipocytes by oxytocin: evidence for mediation of the insulin-like effect by endogenous hydrogen peroxide independent of glucose transport. Arch Biochem Biophys 1982;214:211-222.
84. Mukherjee SP, Mukherjee C, Lynn WS. Activation of pyruvate dehydrogenase in rat adipocytes by concanavalin A: evidence for insulin-like effect mediated by hydrogen peroxide. Biochem Biophys Res Commun 1980;93:36-41.
85. May JM, de Haën C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 1979;254:9017-9021.
86. Czech MP, Lawrence JC Jr, Lynn WS. Evidence for electron transfer reactions involved in the Cu2+-dependent thiol activation of fat cell glucose utilization. J Biol Chem 1974;249:1001-1006.
87. Czech MP, Fain JN. Cu ++-dependent thiol stimulation of glucose metabolism in white fat cells. J Biol Chem 1972;247:6218-6223.
88. Olefsky JM. Comparison of the effects of insulin and insulin-like agents on different aspects of adipocyte metabolism. Horm Metab Res 1979;11:209-213.
89. el-Allawy RM, Gliemann J. Trypsin treatment of adipocytes: effect on sensitivity to insulin. Biochim Biophys Acta 1972;273:97-109.
90. Jain SK, Velusamy T, Croad JL, Rains JL, Bull R. l-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP, MCP-1, and oxidative stress and inhibits NF-kappaB activation in the livers of Zucker diabetic rats. Free Radic Biol Med 2009;46:1633-1638.
91. Ates B, Abraham L, Ercal N. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radic Res 2008;42:372-377.
92. Storozhevykh TP, Senilova YE, Persiyantseva NA, Pinelis VG, Pomytkin IA. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neurosci 2007;8:84.
93. Schmid E, El Benna J, Galter D, Klein G, Dröge W. Redox priming of the insulin receptor β-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 1998;12:863-870.
94. Lin CC, Yin MC. Effects of cysteine-containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet. Br J Nutr 2008;99:37-43.
95. Hsu CC, Huang CN, Hung YC, Yin MC. Five cysteine-containing compounds have antioxidative activity in Balb/cA mice. J Nutr 2004;134:149-152.
96. Obeid OA, Johnston K, Emery PW. Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease. Eur J Clin Nutr 2004;58:105-109.
97. Rush EC, Freitas I, Plank LD. Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr 2009;102:632-641.